These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 15032569)
1. Need for greater scrutiny of days supply values in DACON calculations. Lewis CC; Fiscella RG; Kosty T J Manag Care Pharm; 2004; 10(2):172-3. PubMed ID: 15032569 [No Abstract] [Full Text] [Related]
2. Value Health, Johnson & Johnson collaborate to develop disease management products. Health Care Strateg Manage; 1995 Aug; 13(8):9. PubMed ID: 10144168 [No Abstract] [Full Text] [Related]
3. Strange symbiosis. Navarro RP Med Interface; 1996 Oct; 9(10):78-9, 82. PubMed ID: 10161514 [No Abstract] [Full Text] [Related]
4. Wholesaling in the managed care market. Toscano S Med Interface; 1995 Dec; 8(12):78-81. PubMed ID: 10153522 [No Abstract] [Full Text] [Related]
5. Perspectives on the "generic cliff"--pushing and falling. Curtiss FR J Manag Care Pharm; 2008 Apr; 14(3):318-21. PubMed ID: 18439056 [No Abstract] [Full Text] [Related]
6. Disease management and the drug industry: carve out or carve up? Burns H Lancet; 1996 Apr; 347(9007):1021-3. PubMed ID: 8606567 [No Abstract] [Full Text] [Related]
7. A multidimensional framework for specialty drug management. Bell GK; Baumann SA Manag Care; 2013 Mar; 22(3):30-5. PubMed ID: 23610804 [No Abstract] [Full Text] [Related]
8. Health economics in drug therapy management. Navarro RP Med Interface; 1995 May; 8(5):127-8, 130. PubMed ID: 10142785 [No Abstract] [Full Text] [Related]
9. Medication restrictions: feeling the side effects. Fitzpatrick C Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068 [No Abstract] [Full Text] [Related]
10. Integrating disease state management and pharmaceutical care for cost-effective quality care. Dillon MJ Med Interface; 1995 Oct; 8(10):71, 79. PubMed ID: 10152325 [No Abstract] [Full Text] [Related]
11. Disease management: linking clinical and pharmacy data. Drapin L Health Manag Technol; 1995 May; 16(6):14, 55. PubMed ID: 10142792 [No Abstract] [Full Text] [Related]
13. Drug companies poised to enter risk contracting arena. Capitation Manag Rep; 1998 May; 5(5):65-70. PubMed ID: 10179928 [No Abstract] [Full Text] [Related]
14. Pharmacoeconomics: determining the value of drug therapy. Peterson C Healthplan; 1998; 39(3):44-50. PubMed ID: 10181751 [No Abstract] [Full Text] [Related]
15. User applications of health economics data. Navarro RP Med Interface; 1996 Mar; 9(3):81-2. PubMed ID: 10156017 [No Abstract] [Full Text] [Related]
16. Value-based purchasing. Thomas S; O'Kane M Am J Manag Care; 2012 Nov; 18(11):750-2. PubMed ID: 23198716 [No Abstract] [Full Text] [Related]
17. Precipitating factors for pharmaceutical firms. McCarthy R State Health Care Am; 1997; ():39-43. PubMed ID: 10168083 [No Abstract] [Full Text] [Related]
18. Pharmaceutical industry and payer partnerships to manage costs and improve quality. Mauch RP Manag Care; 2001 Sep; 10(9 Suppl):2-4; discussion 9-12. PubMed ID: 11729438 [No Abstract] [Full Text] [Related]
19. Changing the marketing message. Navarro RP Med Interface; 1995 Jun; 8(6):83-5. PubMed ID: 10142946 [No Abstract] [Full Text] [Related]
20. The next front. Fetter MS Medsurg Nurs; 1998 Aug; 7(4):186-7. PubMed ID: 9782887 [No Abstract] [Full Text] [Related] [Next] [New Search]